A Aralex Aachen research explorer

September 25, 2026 review Open access

Targeting a Moving Threshold: Antigen Density as a Design Constraint for Particulate Drug Delivery in HER2-Low and HER2-Ultralow Breast Cancer—A Narrative Review

DOI: 10.3390/pharmaceutics18101218 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 0 stored of 0

References 2

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies

584

citations
Direct visualization of superselective colloid-surface binding mediated by multivalent interactions
2021 Proceedings of the National Academy of Sciences article Biochemistry, Genetics and Molecular Biology Advanced biosensing and bioanalysis techniques Open access

27

citations

2 results